| Name | Title | Contact Details |
|---|
Affinergy, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Durham, NC. To find more information about Affinergy, Inc., please visit www.affinergy.com
Magellan Diagnostics is a North Billerica, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Eskaton is a nonprofit senior services provider serving Northern California`s older adults for over 50 years. Through innovative approaches to health, housing and social services, Eskaton is Transforming the Aging Experience by offering life-enriching experiences and creating a culture of purposeful living. Well-being is the very center of our philosophy, and we express our belief that Age is Beautiful by celebrating the lives of older adults throughout the Eskaton family. Certified in 2019 as “A Great Place to Work” by Fortune Magazine, Eskaton genuinely cares about the financial security, health and well-being of their staff members. In addition to competitive pay and comprehensive benefits that include a company-funded retirement program, Eskaton employees appreciate knowing their work makes a real difference—both in the community, and in the lives they touch. (129/744) Employment opportunities at Eskaton our wide-ranging, including (but not limited to) the following: • Administration • Nursing • Care-Giving • Maintenance • Dining Services • Housekeeping • Security
It for Health is a San Jose, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Nanoscope Therapeutics is advancing gene therapy using light-sensitive molecules and light-assisted gene delivery for giving sight to the millions of blind individuals suffering from retinal degenerative disease, for which no cure exists. Nanoscope is focused on proprietary ambient light-activated optogenetic therapy to restore vision in people suffering from various inherited retinal degenerative diseases including Retinitis Pigmentosa, Stargardt, and dry AMD. Genetic retinal degenerative diseases cause vision loss as cells of the retina gradually become dysfunctional. Nanoscope`s proprietary gene therapies correct the condition by delivering light-sensitive molecules, called Multi-Characteristic Opsins (MCO), into retinal cells.